Abstract:Telomerase is highly expressed in tumor cells, which has become an important target of anticancer drugs. Since many tumor cells were rich in G4-DNA, we investigated the capabilities of these two ruthenium complexes to stabilize G4-DNA. Two ruthenium(II) complexes were synthesized and characterized via electrospray ionization-mass spectrometry. Since many tumor cells were rich in G4-DNA, we investigated the capabilities of these two ruthenium complexes to stabilize G4-DNA. The interactions of these corn. pounds with G-quadruplex DNA have been studied by fluorescence spectroscopy and circular dichroism (CD) spectroscopy. The stabilization of quadruplex DNA to complex 2 was better than complex 1, and complex 2 can induce telomeric G-quadruplex to occur conformation transformation, while complex 1 cannot. The results showed that the interaction of ruthenium complexes with G-quadruplex DNA was related with the plane of ligand. A novel visual method has been developed for making a distinction between ct-DNA and HTG21 by our Ru complexes binding hemin to form the hemin-G-quadruplex DNAzyme. The results showed that in the presence of complex 1 or 2, HTG21 can fold into a G-quadruplex, but CT-DNA cannot form the G-quadruplex structure. The anticancer activities of these complexes were evaluated by using the MTT assay. Interestingly, the anti-tumor activity of complex 2 exhibited greater inhibition to HepG2 cells, suggesting the ruthenium complexes were much less toxic towards normal cells, and speculated that it targeted the telomeric G-quadruplex was play a role on anti-tumor effect. To further evaluate the characteristics of the death induced by complexes 1 and 2-treated cells staining with Hoechst is analyzed by fluorescence microscopy. These results indicated that complex 2 revealed antiproliferative activities by apoptosis. We also used PI staining and flow cytometry to assess whether the ruthenium complex 2 affected cell cycle progression in HepG2 cells. Complex 2 is a potential antitumor drugs that can induce cancer cell death by acting on cell cycle arrest in G1 phase and the formation of DNA fragments (apoptosis characteristics).

Chiral Ruthenium(Ii) Polypyridyl Complexes: Stabilization of G-Quadruplex Dna, Inhibition of Telomerase Activity and Cellular Uptake

Stabilization of G-quadruplex DNA, Inhibition of Telomerase Activity and Live Cell Imaging Studies of Chiral Ruthenium(ii) Complexes.

Polypyridyl Complexes of Ruthenium(Ii): Stabilization of G-Quadruplex Dna and Inhibition of Telomerase Activity

Chiral RuII‐PtIIComplexes Inducing Telomere Dysfunction Against Cisplatin‐Resistant Cancer Cells

Selective Nuclei Accumulation of Ruthenium(ii) Complex Enantiomers That Target G-quadruplex DNA.

Stabilization of G-quadruplex DNA and Inhibition of Telomerase Activity Studies of Ruthenium(ii) Complexes.

Stabilization of Telomere DNA, and Mechanism of Apoptosis of Tumor Cells Induced by Ruthenium Complexes

Anticancer Activity of Novel Ruthenium Complex with 1,10-Phenanthrolineselenazole As Potent Telomeric G-Quadruplex Inhibitor

Chiral Ruthenium(ii) Anthraquinone Complexes As Dual Inhibitors of Topoisomerases I and II

Targeting telomeric G-quadruplexes with the ruthenium(II) complexes [Ru(bpy)(2)(ptpn)](2+) and [Ru(phen)(2)(ptpn)](2+).

Ruthenium(II) polypyridyl complexes as G-quadruplex inducing and stabilizing ligands in telomeric DNA.

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Dinuclear Ruthenium(ii) Complexes That Induce and Stabilise G-quadruplex DNA.

Ruthenium(ii) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase.

A Ruthenium(ii) Complex Capable of Inducing and Stabilizing Bcl-2 G-quadruplex Formation As a Potential Cancer Inhibitor.

Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes

Novel ruthenium(II) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors.

Ruthenium(II) Polypyridyl Complexes: Cellular Uptake, Cell Image and Apoptosis of HeLa Cancer Cells Induced by Double Targets

Ruthenium (ii) Polypyridyl Complexes Stabilize the Bcl-2 Promoter Quadruplex and Induce Apoptosis of Hela Tumor Cells

Chiral Ruthenium(ii) Complexes with Phenolic Hydroxyl Groups As Dual Poisons of Topoisomerases I and IIα

Novel Polypyridyl Ruthenium Complexes Acting As High Affinity DNA Intercalators, Potent Transcription Inhibitors and Antitumor Reagents.